CoChat

Tyrosine for depression: a double-blind trial

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

We treated 65 outpatients with RDC major depression in a randomized, prospective, double-blind comparison of oral L-tyrosine, 100 mg/kg/day, imipramine, 2.5 mg/kg/day, or placebo for 4 weeks. Tyrosine increased and imipramine decreased 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion significantly, but there was no evidence that tyrosine had antidepressant activity. The only side effect to achieve statistical significance was greater dry mouth with imipramine. MHPG excretion and plasma amino acid concentrations failed to predict or correlate with clinical improvement.

Overview

Integrity signals

Registry

Crossref · 10.1016/0165-0327(90)90017-3

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 14 references

Research works printed but not linked: 1

  1. Mouret, 1988, La L-tyrosine guérit immediatement et à long terme, les dépressions dopamino-dépendantes, C. R. Acad. Sci. Paris, 306, 93

Cited by

See all 73

Metadata

Authors
Gelenberg, A. J., Wojcik, J. D., Falk, W. E., Baldessarini, R. J., Zeisel, S. H., Schoenfeld, D., & Mok, G. S.
Affiliations
  • University of Arizona (US)
  • Harvard University (US)
  • McLean Hospital (US)
  • Boston University (US)
Corresponding author
Gelenberg, Alan J.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
1990-06
Volume
19
Issue
2
Pages
125-132
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2051796892
Cited by
71
References
14
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 2 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 3 · 2012: 2
FWCI
0.42
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Massachusetts General Hospital
  • National Institutes of Health (5k05mh047370-25, 2r01mh036662-04)
  • U.S. Public Health Service
  • National Institute of Mental Health (MH-36662, P01MH031154, MH-31154, MH47370)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
tyrosine, major depressive disorder, imipramine, antidepressant efficacy, plasma amino acids, xerostomia, adverse effects, outpatients
MeSH terms
Adult, Depressive Disorder, Double-Blind Method, Female, Humans, Imipramine, Male, Methoxyhydroxyphenylglycol, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales, Tyrosine, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tyrosine for depression: a double-blind trial. https://app.cochat.ai/papers/10.1016/0165-0327(90)90017-3
The paper
Gelenberg, A. J., Wojcik, J. D., Falk, W. E., Baldessarini, R. J., Zeisel, S. H., Schoenfeld, D., & Mok, G. S. (1990). Tyrosine for depression: a double-blind trial. Journal of Affective Disorders. https://doi.org/10.1016/0165-0327(90)90017-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.